Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis
Description
Objectives: The dysregulated immune response occurring upon COVID-19 infection can lead to tissue damage and organ failure. Different therapeutic strategies are needed to cope with the current and future outspread of COVID-19, including antiviral and
